Junshi Biosciences Announces Final Analysis Results of NEOTORCH Phase 3 Study at ESMO 2026 Congress.
Junshi Biosciences Announces Final Analysis Results of NEOTORCH Phase 3 Study at ESMO 2026 Congress.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in